This finding is consistent with a lower reported incidence of PTEN mutations in ovarian endometrioid adenocarcinomas (17%) versus endometrial endometrioid adenocarcinomas (67%; P value of <0.0001)29. This evidence concerns the gene PTEN and endometrial endometrioid adenocarcinoma.